Medicine recalls
|
| |
| The United Kingdom: Company-led recall: Helixate NexGen |
| |
The Medicines and Healthcare products Regulatory Agency (MHRA) announces that CSL Behring is recalling the Helixate NexGen 250IU, 500IU, 1000IU and 2000IU. The affected batch numbers can be found in the MHRA website. The affected batches were manufactured with active ingredient that has either fallen below the potency specification since release to the market or is at risk of falling below specification prior to expiry.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/helixate-nexgen-active-ingredient-has-fallen-below-the-potency-specification-clda-16-a-06
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/ Friday, August 12, 2016
Issued at HKT 15:00
|
| |
|
